MTND3P10

Across TCGA pan-cancer cohorts, MTND3P10 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated MTND3P10 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MTND3P10 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MTND3P10 expression acts as an unfavorable survival marker, although some lineages such as HNSC and BLCA show a favorable association.

HNSC, BLCA, and ACC are the cancer types where MTND3P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	II,III,IV	0.707	0.555	.002	100	view →
BLCA	OS	Tertile	III,IV	0.802	0.620	.001	59	view →
ACC	OS	Tertile	III,IV	0.390	0.821	<.001	54	view →
UVM	DFS	Tertile	III,IV	0.277	0.675	.001	32	view →
LUAD	DFS	Quartile	IV	0.107	0.807	.004	32	view →
OV	OS	Median	IV	0.254	0.500	.001	32	view →
LGG	DFS	Median	All	0.314	0.456	<.001	28	view →
LAML	DFS	Quartile	All	0.504	0.242	.008	22	view →
CESC	OS	Quartile	II,III,IV	0.885	0.669	.012	12	view →
KIRP	DFS	Tertile	All	1.000	0.687	.041	12	view →
PAAD	DFS	Median	II,III,IV	0.348	0.500	.031	11	view →
THCA	OS	Tertile	IV	0.832	1.000	.035	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

MTND3P10–HNSC (DFS)

Open the HNSC breakdown →